Biotechs ‘in better position to avoid workforce reductions’ as layoffs continue to ease in Q2’26 June 30, 2026Posted inBiotechnology A sharp reduction in layoffs continued in the second quarter, extending a trend that started last fall. Post navigation Previous Post Vistagen fails another phase 3 social anxiety trial but spies path to marketNext PostAbivax rebounds from stock drop with safety data for much-hyped colitis prospect
